Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12Q - Measuring or testing processes involving enzymes or micro-organisms; Compositions or test papers therefor; Processes of preparing such compositions; Condition-responsive control in microbiological or enzymological processes › C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions
Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2003
11/27/2003US20030219380 Indolinone drug; controlling cell differentiation, cell proliferation
11/27/2003US20030219375 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
11/27/2003US20030219357 Applying sample to test strips; calibration using computer; measuring blood glucose; diabetes diagnosis
11/27/2003US20030217966 Techniques to improve polyurethane membranes for implantable glucose sensors
11/27/2003US20030217918 Rapid response glucose sensor
11/27/2003CA2812019A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/27/2003CA2525646A1 Diagnosis of abnormal blood conditions based on polymorphisms in the glycoprotein vi gene
11/27/2003CA2498509A1 Method of detecting gene polymorphism
11/27/2003CA2493825A1 Means for use in treating diseases correlated with or caused by non-physiological levels of microtubule-associated pp2ac
11/27/2003CA2486950A1 Method for producing polymer layers
11/27/2003CA2486583A1 Marker molecules associated with lung tumors
11/27/2003CA2486028A1 Method of identifying pancreatic ductal carcinoma-specific gene using pancreatic ductal cells, method of testing for pancreatic ductal carcinoma using pancreatic ductal carcinoma-specific gene that is identified by the method, and method of screening pharmaceutical candidate compound for treating or preventing pancreatic ductal carcinoma
11/27/2003CA2485983A1 Cancer-linked gene as target for chemotherapy
11/27/2003CA2485650A1 Biosenser having electrode for determining the rate of flow of a fluid
11/27/2003CA2484744A1 Molecular identification of aspergillus species
11/27/2003CA2484642A1 Multiple closed nucleus breeding for swine production
11/27/2003CA2484234A1 Plating media
11/27/2003CA2484176A1 Human obesity susceptibility gene and uses thereof
11/27/2003CA2483694A1 Automated system for isolating, amplifying and detecting a target nucleic acid sequence
11/27/2003CA2483692A1 Constitutively translocating cell line
11/27/2003CA2483688A1 Methods for measuring kinase activity and phosphatase activity
11/27/2003CA2483520A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
11/27/2003CA2481799A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/26/2003EP1365249A1 Biochip and method of manufacturing the biochip
11/26/2003EP1365246A1 Diagnostics and therapeutics for diseases associated with neuromedin U2 receptor (NMU2)
11/26/2003EP1365245A1 Diagnostics and therapeutics for diseases associated with chemokine receptor 11 (CCR11)
11/26/2003EP1365242A1 Compounds for detection and treatment of colorectal lesions
11/26/2003EP1365034A2 Methods and compositions for the prediction, diagnosis, prognosis, prevention and treatment of malignant neoplasia
11/26/2003EP1365033A1 Method of molecular diagnosis of chronic myelogenous leukemia
11/26/2003EP1365032A1 Marker molecules associated with lung tumors
11/26/2003EP1365031A1 Method for detection of somatic mutations using mass spectometry
11/26/2003EP1365030A1 G-protein coupled receptor marker molecules associated with colorectal lesions
11/26/2003EP1365026A1 Dna encoding l-ribose isomerae and use thereof
11/26/2003EP1365022A1 Adiponectin-associated protein
11/26/2003EP1365020A1 Crystal structure and mutants of interleukin-1beta converting enzyme
11/26/2003EP1364702A2 Process for producing array plate for biomolecules having hydrophilic and hydrophobic regions
11/26/2003EP1364224A1 Magnetic resonance spectroscopy to identify and classify microorganisms
11/26/2003EP1364213A2 Screening under isothermal denaturing conditions
11/26/2003EP1364212A2 Three hybrid assay system
11/26/2003EP1364211A1 Method for detecting macromolecular biopolymers by using at least one immobilizing unit provided with a marked scavenger molecule
11/26/2003EP1364207A2 Rapid methods for microbial typing and enumeration
11/26/2003EP1364206A2 Rapid method for screening compounds for in vivo activity
11/26/2003EP1364197A2 High-throughput stem cell assay of hematopoietic stem and progenitor cell proliferation
11/26/2003EP1364071A2 Novel method for analysing phenotypic characteristics of human immunodeficiency virus (hiv)
11/26/2003EP1364070A2 Optoelectronic detection system
11/26/2003EP1364069A1 Method for the development of gene panels for diagnostic and therapeutic purposes based on the expression and methylatoin status of the genes
11/26/2003EP1364068A2 Method and kit for animal species-specific dna identification of a sample
11/26/2003EP1364067A2 Prc17: an amplified cancer gene
11/26/2003EP1364066A2 Method for identifying functional nucleic acids
11/26/2003EP1364065A2 Polynucleotides for use as tags and tag complements, manufacture and use thereof
11/26/2003EP1364064A2 Method for rapid detection and identification of bioagents
11/26/2003EP1364063A2 Detection of herpes simplex virus
11/26/2003EP1364062A2 Diagnostic test for the detection of chromosomal abnormalities in a fetus
11/26/2003EP1364061A2 Model of transmissible spongiform encephalopathic (tse) disease
11/26/2003EP1364060A2 Polymorphisms in the zf9 gene linked to a predisposition for the development of inappropriate scarring or fibrosis
11/26/2003EP1364059A1 Methods for analysis of rna
11/26/2003EP1364058A2 Method for maldi-tof-ms analysis and/or sequencing of oligonucleotides
11/26/2003EP1364057A2 Ligand detection method
11/26/2003EP1364056A2 Method for ultra-high resolution mapping of genes and determination of genetic networks among genes underlying phenotypic traits
11/26/2003EP1364055A2 Solubility reporter gene constructs
11/26/2003EP1364054A2 Method of determining a chemotherapeutic regimen based on ercc1 expression
11/26/2003EP1364053A2 Expression analysis of smarc nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
11/26/2003EP1364052A2 High throughput or capillary-based screening for a bioactivity or biomolecule
11/26/2003EP1364051A2 Screening methods to identify compounds that modulate a response of a cell to ultraviolet radiation exposure
11/26/2003EP1364050A2 Method for the diagnosis and follow up of schizophrenia and other mental and neurodegenerative disorders
11/26/2003EP1364049A2 Molecular toxicology modeling
11/26/2003EP1364048A2 Method of performing subtractive hybridization
11/26/2003EP1364047A2 Targeting of dna sequences by the use of recombinase coated dna probes
11/26/2003EP1364046A2 Methods for genetic analysis of dna to detect sequence variances
11/26/2003EP1364045A2 Determining the risk of caries in a patient
11/26/2003EP1364043A1 Methods and kits for identifying scavengers of reactive oxygen species (ros)
11/26/2003EP1364031A1 Hiv-like particles and the use thereof
11/26/2003EP1364021A2 Compositions and methods relating to colon specific genes and proteins
11/26/2003EP1364019A2 Methods and compositions relating to muscle specific sarcomeric calcineurin-binding proteins (calsarcins)
11/26/2003EP1364018A2 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof
11/26/2003EP1364017A2 Inflammation related g-protein coupled receptor
11/26/2003EP1364015A2 Molecules for diagnostics and therapeutics
11/26/2003EP1364014A2 Novx proteins and nucleic acids encoding same. diagnostic and therapeutic uses
11/26/2003EP1364009A2 Regulatable, catalytically active nucleic acids
11/26/2003EP1364007A1 Circular extra-chromosomal dna elements
11/26/2003EP1363998A1 Novel human poly(a)polymerase gamma (pap gamma)
11/26/2003EP1363996A2 Epothilone resistant cell lines
11/26/2003EP1363991A2 Self-spreading microbiological culture device
11/26/2003EP1363948A1 Polypeptide of a p53 protein-specific murine alpha/beta t-cell receptor, nucleic acids coding therefor and use thereof
11/26/2003EP1363946A2 Methods of dissociating nongenotropic from genotropic activity of steroid receptors
11/26/2003EP1363942A2 Polypeptide from a hdm2 protein specific murine alpha/beta t-cell receptors, nucleic acids coding for the above and use thereof
11/26/2003EP1363941A2 Histidine phosphatase interacting protein of 120 kd
11/26/2003EP1363940A1 Tumour peptide antigen produced from human mdm2 proto-oncogene
11/26/2003EP1363936A1 Juvenile hormone esterase
11/26/2003EP1363935A2 Ter sites and ter binding proteins
11/26/2003EP1363930A1 A method for generating genetically altered antigens
11/26/2003EP1363920A1 Modified psma ligands and uses related thereto
11/26/2003EP1363736A2 Automated laboratory system and method
11/26/2003EP1363662A2 Mhc-i-restricted presentation of hiv-1 virion antigens without viral replication. application to the stimulation of ctl and vaccination in vivo ; analysis of vaccinating composition in vitro
11/26/2003EP1363655A2 Isolated nucleic acid molecules encoding a human and mouse g protein-coupled receptor - gpr54; encoded proteins, cells transformed therewith and uses thereof
11/26/2003EP1363654A2 Fab i and inhibition of apicomplexan parasites
11/26/2003EP1363640A2 Nucleic acid derivatives
11/26/2003EP1363529A2 Rare event detection system
11/26/2003EP1363528A2 Methods for diagnosing and treating heart disease
11/26/2003EP1224471B1 Dpi-6, a therapeutic biomarker in neurological disorders
1 ... 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 ... 3003